Jonathan Y. Wong, None; Mauro T. Leite, None; Roman G. Fajardo, None; Ali Tafreshi, None; Linda M. Zangwill, Carl Zeiss Meditec Inc. (F), Heidelberg Engineering (R), Heidelberg Engineering GmbH (F), Optovue Inc. (F), Topcon Medical Systems Inc. (F); Robert N. Weinreb, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (F, C), Heidelberg Engineering GmbH (F), Merck Inc. (C), Novartis (F), Optovue Inc. (F, C), Pfizer Inc. (C), Topcon Medical Systems Inc. (F); Christopher A. Girkin, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (R), Heidelberg Engineering Inc. (R), Merck Inc. (R), Optive Inc. (R), Pfizer Inc. (C), Topcon Medical Systems Inc. (R); Jeffrey M. Liebmann, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (F), Dyopsis Corp. (F, C), Heidelberg Engineering Inc. (F), Optovue Inc. (F, C), Pfizer Inc. (C), Topcon Medical Systems Inc. (F, C); Pamela A. Sample, Carl Zeiss Meditec Inc. (F), Haag-Streit (F); Felipe A. Medeiros, Alcon Laboratories Inc. (F, C, R), Allergan Inc. (C, R), Carl Zeiss Meditec Inc. (F, R), Merck Inc. (F), Pfizer Inc. (F, C, R), Reichert Inc. (R)